These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 30375263)

  • 1. The Shiraz Breast Cancer Registry (SBCR): study design and primary reports.
    Talei A; Tahmasebi S; Akrami M; Zangouri V; Rezaianzadeh A; Arasteh P; Eghbali T; Hosseini S
    Per Med; 2018 Nov; 15(6):471-479. PubMed ID: 30375263
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epidemiology and biological characteristics of male breast cancer in Italy.
    Mangone L; Ferrari F; Mancuso P; Carrozzi G; Michiara M; Falcini F; Piffer S; Filiberti RA; Caldarella A; Vitale F; Tumino R; Brustolin A; Tagliabue G; Giorgi Rossi P; Ottini L
    Breast Cancer; 2020 Jul; 27(4):724-731. PubMed ID: 32114665
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence of primary breast cancer in Iran: Ten-year national cancer registry data report.
    Jazayeri SB; Saadat S; Ramezani R; Kaviani A
    Cancer Epidemiol; 2015 Aug; 39(4):519-27. PubMed ID: 26070507
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determinants of Prognosis in Triple-Negative Breast Cancer: Report from a Large Breast Cancer Registry.
    Tahmasebi S; Almayali AMJ; Arasteh P; Akrami M; Zangouri V; Arasteh P; Hosseini SM; Salehi Nobandegani A; Asgari A; Sadeghi E; Zahiri L; Talei A
    Arch Iran Med; 2021 Apr; 24(4):280-288. PubMed ID: 34196187
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of triple-negative and estrogen receptor-positive/progesterone receptor-positive/HER2-negative breast carcinoma using quantitative fluorine-18 fluorodeoxyglucose/positron emission tomography imaging parameters: a potentially useful method for disease characterization.
    Basu S; Chen W; Tchou J; Mavi A; Cermik T; Czerniecki B; Schnall M; Alavi A
    Cancer; 2008 Mar; 112(5):995-1000. PubMed ID: 18098228
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trends in epidemiology, clinical and histopathological characteristics of breast cancer in Iran: results of a 17 year study.
    Afsharfard A; Mozaffar M; Orang E; Tahmasbpour E
    Asian Pac J Cancer Prev; 2013; 14(11):6905-11. PubMed ID: 24377624
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Breast Cancer in Iranian Woman: Incidence by Age Group, Morphology and Trends.
    Rafiemanesh H; Salehiniya H; Lotfi Z
    Asian Pac J Cancer Prev; 2016; 17(3):1393-7. PubMed ID: 27039778
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Breast Cancer in Men: a Report from the Department of Radiation Oncology in Kermanshah Province, Iran.
    Amirifard N; Sadeghi E
    Asian Pac J Cancer Prev; 2016; 17(5):2593-6. PubMed ID: 27268636
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronological changes and trend of breast cancer clinics and pathology among Iranian women during 22 years from the largest breast cancer registry in Iran.
    Tahmasebi S; Tajali M; Akrami M; Arasteh P; Zangouri V; Nobandegani AS; Hosseini SM; Safari A; Talei A
    World J Surg Oncol; 2019 Dec; 17(1):207. PubMed ID: 31801561
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Male breast cancer; analysis of 58 cases in Shiraz, South of Iran.
    Tahmasebi S; Akrami M; Omidvari S; Salehi A; Talei A
    Breast Dis; 2010; 31(1):29-32. PubMed ID: 20644250
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinicopathologic characteristics of male breast cancer: a report of 21 cases in radiotherapy center of hamedan, iran.
    Sedighi A; Hamed EA; Mohammadian K; Behnood S; Kalaghchi B
    Asian Pac J Cancer Prev; 2013; 14(12):7381-3. PubMed ID: 24460307
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trends of breast cancer and its management in the last twenty years in Aden and adjacent governorates, Yemen.
    Harhra NA; Basaleem HO
    Asian Pac J Cancer Prev; 2012; 13(9):4347-51. PubMed ID: 23167341
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is breast cancer from Sub Saharan Africa truly receptor poor? Prevalence of ER/PR/HER2 in breast cancer from Kenya.
    Sayed S; Moloo Z; Wasike R; Bird P; Oigara R; Govender D; Kibera J; Carrara H; Saleh M
    Breast; 2014 Oct; 23(5):591-6. PubMed ID: 25012047
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Histopathological features of breast cancer in Al-Madinah region of Saudi Arabia.
    Albasri A; Hussainy AS; Sundkji I; Alhujaily A
    Saudi Med J; 2014 Dec; 35(12):1489-93. PubMed ID: 25491214
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Breast cancer in Cameroon, histo-epidemiological profile: about 3044 cases].
    Engbang JP; Essome H; Koh VM; Simo G; Essam JD; Mouelle AS; Essame JL
    Pan Afr Med J; 2015; 21():242. PubMed ID: 26523182
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pattern of breast cancer in a tertiary care center.
    Jha AK; Hamal PK; Jha J; Banthia P; Thakali K; Basnet BK
    JNMA J Nepal Med Assoc; 2010; 49(177):1-5. PubMed ID: 21180211
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Abundant tumor infiltrating lymphocytes after primary systemic chemotherapy predicts poor prognosis in estrogen receptor-positive/HER2-negative breast cancers.
    Watanabe T; Hida AI; Inoue N; Imamura M; Fujimoto Y; Akazawa K; Hirota S; Miyoshi Y
    Breast Cancer Res Treat; 2018 Feb; 168(1):135-145. PubMed ID: 29168063
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular profile of breast cancers in Guinean oncological settings.
    Traoré B; Koulibaly M; Diallo A; Bah M
    Pan Afr Med J; 2019; 33():22. PubMed ID: 31312338
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BRCA1 and BRCA2 mutations in males with familial breast and ovarian cancer syndrome. Results of a Spanish multicenter study.
    de Juan I; Palanca S; Domenech A; Feliubadaló L; Segura Á; Osorio A; Chirivella I; de la Hoya M; Sánchez AB; Infante M; Tena I; Díez O; Garcia-Casado Z; Vega A; Teulé À; Barroso A; Pérez P; Durán M; Carrasco E; Juan-Fita MJ; Murria R; Llop M; Barragan E; Izquierdo Á; Benítez J; Caldés T; Salas D; Bolufer P
    Fam Cancer; 2015 Dec; 14(4):505-13. PubMed ID: 26026974
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Annual report of the Japanese Breast Cancer Registry for 2017.
    Hayashi N; Kumamaru H; Isozumi U; Aogi K; Asaga S; Iijima K; Kadoya T; Kojima Y; Kubo M; Miyashita M; Miyata H; Nagahashi M; Niikura N; Ogo E; Tamura K; Tanakura K; Yamamoto Y; Yoshida M; Imoto S; Jinno H
    Breast Cancer; 2020 Sep; 27(5):803-809. PubMed ID: 32710374
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.